ClinicalTrials.gg
CompletedNCT05956353Updated Apr 11, 2024

Stories for Change: Early Detection Can Save Lives

An interventional study of Digital Storytelling Intervention in Prevention, sponsored by Mayo Clinic. Completed at 3 sites in United States. Open to participants aged 21 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-04-11.

Sponsored by Mayo Clinic · Not applicable, Interventional, and Screening

Phase
Not applicable
Study type
Interventional
Enrollment
51
Allocation
Not applicable
Ages
21 Years to 75 Years
Sex
All
01

Study summary

The purpose of this study is to evaluate the Stories for Change (S4C) Cancer Prevention digital storytelling intervention for acceptability and socio-behavioral constructs to increase cancer screening among Hispanic or Latino individuals.

02

Conditions studied

  • Prevention
03

In context

Lead sponsor

Mayo Clinic is the lead sponsor of 3,264 studies on the registry; 670 are open to participants now.

Of its 450 completed or terminated interventional studies of FDA-regulated products, 318 (71%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Self-identify as Hispanic, Latino/a/x/e, or Chicano/a/x;
  • For breast cancer screening: age 40-74 years; for cervical cancer screening: age 21-65 years; for colorectal cancer screening: age 45-75 year
  • Receive primary care at either Hennepin Healthcare (HH) or Mountain Park Health Center (MPHC), or Mayo Clinic.
  • At least one office visit within the previous 12 months to the primary care site.
  • Eligibility for breast, cervical, or colorectal cancer screening documented in the electronic medical record (EMR).
  • Intention to continue to receive medical care at HH, MPHC or Mayo Clinic for the next three months.

If a potential participant is eligible for more than one screening, they will be given the option of participating in multiple versions of the intervention.

Exclusion criteria

Exclusion Criteria:

  • Individuals with previous breast, cervical, or colorectal cancer diagnoses.
  • For the participants in the colorectal cancer screening intervention, those under surveillance (i.e., did not have a cancer diagnosis but did have polyps) will also be excluded.
05

Study design

Phase
Not applicable
Primary purpose
Screening
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
51 participants (actual)

Study arms

  • Experimental
    Stories for Change: Prevention (S4C) intervention

    Participants who are due or overdue for cancer screening will receive the digital storytelling intervention and complete a cross-sectional survey to assess intervention acceptability, socio-behavioral constructs, and theory-based constructs.

    Behavioral: Digital Storytelling Intervention

Interventions

  • BehavioralDigital Storytelling Intervention

    Culturally tailored narrative-based videos created by individuals to promote colorectal, breast and cervical cancer screening among eligible participants in a primary care practice.

06

What researchers measure

Primary outcomes

  1. Number of participants screened and recruited

    Our primary measure is the number of participants screened and recruited. We need this information to calculate the number needed to screen in order to recruit one participant from each site in our future randomized controlled trial.

    Time frame: 1 year

Secondary outcomes

  1. Constructs associated with effective implementation research

    Our secondary measure will utilize the Consolidated Framework for Implementation Research. We need this information to identify recruitment successes and opportunities for change in our future randomized controlled trial.

    Time frame: 1 year

07

Study locations

3 sites
  • Moutain Park Health Center
    Phoenix, Arizona 85012, United States
  • Hennepin Healthcare
    Minneapolis, Minnesota 55415, United States
  • Mayo Clinic Minnesota
    Rochester, Minnesota 55905, United States
08

References and documents

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Aug 2023 to primary completion in Mar 2024, 7 months.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 27, 2023
First posted
Jul 21, 2023
StartActual
Aug 1, 2023
Primary completionActual
Mar 31, 2024
CompletionActual
Mar 31, 2024
Last update
Apr 11, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 11, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05956353
Lead sponsor
Mayo Clinic
Responsible party
Mark L Wieland (Principal Investigator, Mayo Clinic) — Principal investigator
First posted
Jul 21, 2023
Start date
Aug 1, 2023
Primary completion
Mar 31, 2024
Completion
Mar 31, 2024
Last update
Apr 11, 2024

Study contacts

Mark Weiland, MD
principal investigator · Mayo Clinic

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion